Výsledky vyhledávání - "Sagar K Rajbhandari"

Comparative genomic analyses of multi-drug resistant Mycobacterium tuberculosis from Nepal and other geographical locations

Autor: Kelvin W.C. Leong, Sanjay S. Gautam, Manoj Pradhan, Y. Ibotomba Singh, Rajendra KC, Sagar K. Rajbhandari, Gokarna R. Ghimire, Krishna Adhikari, Uma Shrestha, Raina Chaudhary, Gyanendra Ghimire, Sundar Khadka, Ronan F. O'Toole

Publikováno v: Genomics. 114:110278

Nepal exhibits a tuberculosis (TB) incidence rate that is comparable to neighbouring high TB incidence countries. In addition, it records500 cases of multi-drug resistant (MDR) TB each year. The objective of this study was to perform whole-genome bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba25fe3f5c3ceedf778a5160ea20680c
https://doi.org/10.1016/j.ygeno.2022.110278

Zobrazit plný text záznamu

Draft Genome Sequence of an Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis from Nepal

Autor: Gyanendra Ghimire, Sundar Khadka, Y. Ibotomba Singh, Kelvin W. C. Leong, Sagar K. Rajbhandari, Gokarna R. Ghimire, Krishna Adhikari, Uma Shrestha, Ronan F. O’Toole, Raina Chaudhary, Manoj Pradhan, Sanjay S. Gautam

Publikováno v: Microbiology Resource Announcements

Extensively drug-resistant (XDR) Mycobacterium tuberculosis has become a challenge to the treatment of tuberculosis (TB) in several countries, including Nepal. Here, we report for the first time the draft genome sequence of an isolate of XDR-TB colle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b57a1e20adf5989ea110cff45afccafa
https://doi.org/10.1128/mra.01404-19

Zobrazit plný text záznamu

Adverse events following immunization with Covi-shield tm vaccine: a descriptive cross-sectional study at a tertiary center, Nepal

Autor: Gopal Lama, Runa Jha, Sagar K Rajbhandari, Jenish Neupane, Anup Bastola

Publikováno v: International Journal of Multidisciplinary Research and Growth Evaluation. :163-163

Introduction: As the COVID-19 pandemic continues to unfold, rapid global efforts to develop and test vaccines against SARS-CoV-2 have started. Adverse events after immunization are a common issue seen in many vaccines. This study aims at finding the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cce16b95452be1d8a7803041df2ba671
https://doi.org/10.54660/anfo.2021.2.6.10

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání